We established a cell line derived from a hTS/Ink4a/Arf−/− splenic tumor, designated hTS5278 (see detail description in Material and Methods) that was further infected with the luciferase reporter to track cells in vivo (Luc-hTS5278). Here, CDKN2A is linked to neoplasm.